Assessing the ethics of prior authorization denials and step therapy policies in dermatology
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:90 |
|---|---|
| Enthalten in: |
Journal of the American Academy of Dermatology - 90(2024), 4 vom: 15. März, Seite 877-878 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sedghi, Tannaz [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jaad.2023.02.018 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353285978 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353285978 | ||
| 003 | DE-627 | ||
| 005 | 20240325234144.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaad.2023.02.018 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1346.xml |
| 035 | |a (DE-627)NLM353285978 | ||
| 035 | |a (NLM)36822353 | ||
| 035 | |a (PII)S0190-9622(23)00269-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sedghi, Tannaz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Assessing the ethics of prior authorization denials and step therapy policies in dermatology |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2024 | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Ethics | |
| 650 | 4 | |a atopic dermatitis | |
| 650 | 4 | |a beneficence | |
| 650 | 4 | |a biologics | |
| 650 | 4 | |a clinical practice | |
| 650 | 4 | |a dupilumab | |
| 650 | 4 | |a insurance | |
| 650 | 4 | |a nonmaleficence | |
| 650 | 4 | |a payor | |
| 650 | 4 | |a prior authorization | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 700 | 1 | |a Gronbeck, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Aiudi, Donna A |e verfasserin |4 aut | |
| 700 | 1 | |a Grant-Kels, Jane M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Academy of Dermatology |d 1984 |g 90(2024), 4 vom: 15. März, Seite 877-878 |w (DE-627)NLM000422703 |x 1097-6787 |7 nnns |
| 773 | 1 | 8 | |g volume:90 |g year:2024 |g number:4 |g day:15 |g month:03 |g pages:877-878 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaad.2023.02.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 90 |j 2024 |e 4 |b 15 |c 03 |h 877-878 | ||